Trials / Completed
CompletedNCT04643288
Nanocrystalline Hydroxyapatite Bone Substitute for Treating Periodontal Intrabony Defects
Clinical and Radiographic Evaluation of Open Flap Debridement With or Without Nanocrystalline Hydroxyapatite Bone Graft in Management of Periodontal Intrabony Defects
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Weam Ahmed Elbattawy · Academic / Other
- Sex
- All
- Age
- 35 Years – 56 Years
- Healthy volunteers
- Not accepted
Summary
The present clinical trial included 20 patients (11 females and 9 males, aged 36 to 56 years) suffering from moderate or advanced chronic periodontitis. Subjects were recruited from the outpatient clinic, Department of Oral Medicine and Periodontology, Faculty of Dentistry, Cairo University. This clinical trial was meant to assess clinically and radiographically the possible predictable results regarding the use of nanocrystalline hydroxyapatite bone graft substitute together with open flap debridement versus open flap debridement alone in the treatment of periodontal intrabony defects.
Detailed description
periodontal intrabony defects in patients with moderate or advanced chronic periodontitis were treated with open flap debridement only in the control group while open flap debridement and Nanocrystalline Hydroxyapatite bone graft substitute was performed for the intervention group. probing pocket depth, clinical attachment level, gingival index, plaque index, gingival recession and bone defect area were assessed at baseline and six months post surgically to evaluate the possible improvement in the clinical and radiographic outcomes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | open flap debridement | open flap debridement for managing two and three walls intrabony periodontal defects |
| PROCEDURE | n-HA bone graft | Nanocrystalline Hydroxyapatite bone graft substitute for managing two and three walls intrabony periodontal defects |
Timeline
- Start date
- 2018-09-01
- Primary completion
- 2019-11-25
- Completion
- 2020-05-25
- First posted
- 2020-11-25
- Last updated
- 2020-11-27
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04643288. Inclusion in this directory is not an endorsement.